The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report

BACKGROUND: The management of Acute Myeloid Leukemia (AML) during pregnancy remains challenging as both the maternal and fetal outcomes should be considered. Several reports suggested that chemotherapy can be administered safely during the second and third trimester of pregnancy. However, the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrajhi, Abdullah M., Alhazzani, Sarah A., Alajaji, Nouf M., Alnajjar, Fouad H., Alshehry, Nawal F., Tailor, Imran K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822434/
https://www.ncbi.nlm.nih.gov/pubmed/31672129
http://dx.doi.org/10.1186/s12884-019-2522-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822434/
https://www.ncbi.nlm.nih.gov/pubmed/31672129
http://dx.doi.org/10.1186/s12884-019-2522-1

Ejemplares similares